Synonyms: compound 1 [PMID: 30044619] | Evrysdi® | RG-7916 | RG7916 | RO-7034067 | RO7034067
risdiplam is an approved drug (FDA (2020), EMA (2021))
Compound class:
Synthetic organic
Comment: Risdiplam is a first-in-class, orally bioavailable splicing modifier [3]. Like the splice switching oligonucleotide nusinersen, risdiplam is intended to improve the efficiency of SMN2 (HGNC ID 11118; Uniprot Q16637) gene transcription in patients with spinal muscular atrophy (SMA) [2]. Risdiplam binds directly to the SMN2 pre-mRNA to modulate its splicing pattern to produce a protein that compensates for the defective SMN1 gene.
|
|
Download 2D Structure ![]() |
|
Canonical SMILES | Download |
Isomeric SMILES | Download |
InChI standard identifier | Download |
InChI standard key | Download |
Molecular structure representations generated using Open Babel